Ex-Medtronic CEO testifies in Gupta insider trading trial; Boston Heart Diagnostics launches new test;

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> Former Medtronic CEO William George, now a Goldman Sachs director, testified in Rajat Gupta's insider trading trial. Story

> Germany's INJEX Pharma has gained FDA clearance to market the company's needle-free injection device. Release

> Pennsylvania's Teleflex won 510(k) clearance for its new closed tip, multi-port epidural catheter. Release

> Boston Heart Diagnostics is launching a new Statin Induced Myopathy Genotype test designed to diagnose patients at risk of developing myopathy, as a side effect related to statin drugs. Release

> Austria's Miracor Medical Systems has nailed down a number of new U.S. patents for its PICSO (pressure-controlled intermittent coronary sinus occlusion) system to treat severe heart attack patients. Release

Pharma News

 @FiercePharma:  Endo's lobbying yields a provision in House user-fee bill that could protect its Lidoderm patch--NYTMore | Follow @FiercePharma

> Another FDA warning for J&J's McNeil unit. News

> Endo seeks protections in House FDA reauthorization. Item

> Stada must join the generics buyout binge, CEO says. Story

> How does Genentech like it under Roche's wing? Article

Biotech News

 @FierceBiotech: California's CIRM votes to shift stem cell grants toward clinical development side. More | Follow @FierceBiotech

 @JohnCFierce: In fresh setback, Alnylam's most advanced drug flunks PhIIb RSV test. (Not what they need right now.) Item | Follow @JohnCFierce

 @RyanMFierce: 23andMe's Google ties make today's news of the gene patent less surprising. News | Follow @RyanMFierce

> Trial vets at Flexion claim PhIIb success with lead osteoarthritis drug. Article

> China readies plan to spur its booming biotech sector. Story

> Bristol-Myers pushes latest blockbuster cancer drug prospect into ASCO spotlight. Report

> BMS creates global cancer drug collaboration. More

Drug Delivery News

 @DamianFierce: Perhaps you can have too much of a good thing. Penn researchers say too many nanocarriers render treatments ineffective: Story | Follow @DamianFierce

> MIT develops needle-free jet injector. More

> Delivery firm seeks $3M for transdermal platform. Story

> West Pharma looks to cash in on biosimilar delivery. Report

> IntelGenx eyes FDA nod with anti-migraine film results. Item

Biomarkers News

> Biomarkers help select the most fertile donors. News

> The economics and value of genetic biomarkers. Story

> Fitness as a biomarker in breast cancer. More

> Bile duct biomarker screening for fluke-linked cancer. Article

And Finally... Chembio Diagnostics is in the final stages of gearing up to start trading on the Nasdaq capital market. Release